November 10, 2008 By:
Julio Fernandez, Pharm.D.
|
Barr Pharmaceuticals has received final FDA approval for galantamine, its generic version of Ortho McNeil Janssen's Razadyne ER, for the treatment of mild to moderate dementia of the Alzheimer's type.

June 18, 2008 By:
Heidi Belden, Pharm.D.
|
Increased mortality risk warning necessary for off-label use of antipsychotics.

December 10, 2007 By:
Reid Paul
|
Patience and cooperation have been the hallmarks of an award-winning career in Alzheimer's care for pharmacist Robert Cluxton.

November 19, 2007 By:
Sandra Levy
|
Peggy Memoli is recognized for her work with Alzheimer's patients. She is one of three recipients of 2007 Eisai award recognizing the role of pharmacists in Alzheimer's care.

November 5, 2007 By:
Michael Barbella
|
Efforts to educate others about Alzheimer's disease earns hospital pharmacist Eisai award.

November 5, 2007

|
Three pharmacists are the proud recipients of Eisai's hhc (human health care) Pharmacist Recognition Award.

Researchers have found that patients that used statin drugs had fewer signs associated with Alzheimer's disease. Statins may impact Alzheimer's patients

July 23, 2007 By:
Dennis Blank
|
Drug therapies for Alzheimer's disease, have the ability to reduce functional and cognitive decline but don't necessarily work for all patients.

January 22, 2007 By:
Greg Powell, R. Ph.
|
I know the jury is still out on this issue, but I firmly believe mercury exposure is to blame for Alzheimer's disease (AD). It's a subject I feel strongly about because my grandmother is a victim of this horrible condition. I can see firsthand the toll it takes on patients and their families. Even though my grandmother is still alive at 89 years old, she is often so disoriented and confused, it's almost as if she's not here.
